Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2010-04-14 | Mr. Lampropoulos has been involved in and holds more than 100 patents on devices used in the diagnosis and therapeutic treatment of cardiovascular disease. |
| 2011-04-11 | Mr. Lampropoulos has been Chairman of the Board, Chief Executive Officer ("CEO") and President of the Company since its formation in July 1987. He has been involved in and holds more than 100 patents on devices used in the diagnosis and therapeutic treatment of cardiovascular disease. |
| 2012-04-11 | He holds more than 100 patents on devices used in the diagnosis and therapeutic treatment of cardiovascular disease. |
| 2013-04-11 | He holds more than 100 patents on devices used in the diagnosis and therapeutic treatment of cardiovascular disease. |
| 2014-04-25 | Mr. Lampropoulos was Chairman of the Board and President of Utah Medical Products, Inc., a medical device manufacturer. He holds more than 100 patents on devices used in the diagnosis and therapeutic treatment of cardiovascular disease. |
| 2015-04-10 | Fred P. Lampropoulos, 65, has been Chairman of the Board, Chief Executive Officer (“CEO”) and President of the Company since its formation in July 1987. From 1983 to June 1987, Mr. Lampropoulos was Chairman of the Board and President of Utah Medical Products, Inc., a medical device manufacturer. He holds more than 100 patents on devices used in the diagnosis and therapeutic treatment of cardiovascular disease. |
| 2016-04-11 | He holds more than 100 patents on diagnostic and therapeutic devices. The Board believes the Company benefits immensely from Mr. Lampropoulos’ experience as founder, Chief Executive Officer and President of the Company. |
| 2017-04-11 | Mr. Lampropoulos holds more than 200 domestic and international patents and pending applications on diagnostic and therapeutic devices. He serves on several community and advisory boards and has been the recipient of numerous awards. |
| 2018-04-13 | Chair of the Board, CEO, and President of the Company since its formation in July 1987; Filed more than 200 domestic and international patents and applications on medical devices |
| 2019-04-11 | Filed more than 200 domestic and international patents and applications on medical devices |
| 2020-05-27 | Filed more than 200 domestic and international patents and applications on medical devices; Chair, President, CEO of Merit Medical Systems, Inc. |
| 2021-04-30 | Chair of the Board, Chief Executive Officer (CEO) and President of the Company since its formation in 1987; filed more than 300 domestic and international patents and applications on medical devices. |
| 2022-04-07 | Chair, President & CEO of Merit; filed more than 300 patents on medical devices. |
| 2023-04-04 | Fred P. Lampropoulos - Chair, President & CEO of Merit; filed more than 300 patents on medical devices; no software or programming background mentioned. |
| 2024-04-02 | Chair, President & CEO of Merit; filed more than 300 domestic and international patents on medical devices; no mention of software or programming skills. |
| 2025-04-01 | Chair, President & CEO of Merit; Filed more than 300 domestic and international patents and applications on medical devices |
Data sourced from SEC filings. Last updated: 2025-07-16